C12Y 307/01
In ketonic substances
Official title: in ketonic substances (3.7.1)
C12Y307/01 (In ketonic substances) appears on 18 US grants and 38 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 38
- Assignees
- 18
- Inventors
- 73
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 1 | 4 |
| 2018 | 1 | 0 |
| 2019 | 2 | 6 |
| 2020 | 1 | 4 |
| 2021 | 2 | 8 |
| 2022 | 3 | 4 |
| 2023 | 3 | 2 |
| 2024 | 2 | 3 |
| 2025 | 0 | 2 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 307/01003Kynureninase11
- C12Y 307/01002Fumarylacetoacetase3
- C12Y 307/010092-hydroxymuconate-semialdehyde hydrolase2
- C12Y 307/01001Oxaloacetase1
- C12Y 307/01007Beta-diketone hydrolase1
- C12Y 307/01004Phloretin hydrolase0
- C12Y 307/01005Acylpyruvate hydrolase0
- C12Y 307/01006Acetylpyruvate hydrolase0
All 20 subgroupsShow fewer
- C12Y 307/010082,6-dioxo-6-phenylhexa-3-enoate hydrolase0
- C12Y 307/0101Cyclohexane-1,3-dione hydrolase0
- C12Y 307/01011Cyclohexane-1,2-dione hydrolase0
- C12Y 307/01012Cobalt-precorrin 5a hydrolase0
- C12Y 307/010132-hydroxy-6-oxo-6-hexa-2,4-dienoate hydrolase0
- C12Y 307/010142-hydroxy-6-oxonona-2,4-dienedioate hydrolase0
- C12Y 307/01015-caryolan-1-ol synthase0
- C12Y 307/01016Oxepin-coa hydrolase0
- C12Y 307/010174,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1,2-diene-4-oate hydrolase0
- C12Y 307/010186-oxocamphor hydrolase0
- C12Y 307/010192,6-dihydroxypseudooxynicotine hydrolase0
- C12Y 307/01023-fumarylpyruvate hydrolase0
Recent patents
- Pegylated kynureninase enzymes and uses thereof for the treatment of cancer28 Jul 2026US 12,692,485 B2Board of Regents, The University of Texas System
- Administration of kynurenine depleting enzymes for tumor therapy14 Jul 2026US 12,680,089 B2Board of Regents, The University of Texas System
- Human Kynureninase enzymes and uses thereof19 Nov 2024US 12,144,828 B2Board of Regents, The University of Texas System
- Polyvinyl alcohol-degrading enzyme and process for producing the same2 Jan 2024US 11,859,229 B2Hayashibara Co., Ltd.
- Fumarylacetoacetate hydrolase (FAH)-deficient and immunodeficient rats and uses thereof24 Oct 2023US 11,793,178 B2Yecuris Corporation
- Viral vector compositions and methods of use thereof12 Jun 2025US 2025/0188488 A1LogicBio Therapeutics, Inc.
- Gene therapy for the treatment of ht15 Jun 2025US 2025/0177564 A1LogicBio Therapeutics, Inc.
- Process for preparation of phloroglucinol and phenolic derivatives31 Oct 2024US 2024/0360485 A1
- Administration of kynurenine depleting enzymes for tumor therapy21 Mar 2024US 2024/0091258 A1Board of Regents, The University of Texas System
- Microorganisms converting inositol to butyrate25 Jan 2024US 2024/0026310 A1Enbiosis Biotechnology Limited
Most cited
By later US patents
- Administration of kynurenine depleting enzymes for tumor therapy19US 9,808,486 B2Board of Regents, The University of Texas System · 2017
- Administration of kynurenine depleting enzymes for tumor therapy9US 9,975,959 B2Board of Regents, The University of Texas System · 2018
- Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells7US 11,471,494 B2Synlogic Operating Company, Inc. · 2022
- Administration of kynurenine depleting enzymes for tumor therapy6US 10,772,913 B2Board of Regents, The University of Texas System · 2020
- Administration of kynurenine depleting enzymes for tumor therapy5US 11,168,142 B2Board of Regents, The University of Texas System · 2021